Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment

被引：4

作者：

Zhang, Nini ^{[1
]}

Fan, Xinhui ^{[1
]}

Zhang, Yuyu ^{[2
]}

Xu, Ning ^{[3
]}

Li, Li ^{[4
]}

机构：

[1] Yanan Univ, Sch Med, Yanan 716000, Shaanxi, Peoples R China

[2] Fourth Mil Med Univ, Xijing Hosp, Dept Gen Practice, Xian 710032, Shaanxi, Peoples R China

[3] First Hosp Yulin, Dept Crit Care Med, Yulin 719000, Shaanxi, Peoples R China

[4] First Hosp Yulin, Dept Resp Med, Yulin 719000, Shaanxi, Peoples R China

来源：

RESPIRATORY CARE | 2023年 / 68卷 / 12期

关键词：

COPD; inhaled corticosteroids; fracture; osteoporosis; randomized controlled trials; meta-analysis; OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE/SALMETEROL 250/50; 100/25; MU-G; LUNG-FUNCTION; RANDOMIZED-TRIAL; DOUBLE-BLIND; PROPIONATE; SALMETEROL; FUROATE/VILANTEROL; EXACERBATIONS;

D O I：

10.4187/respcare.10933

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the incidence of fracture or osteoporosis among patients with COPD. The aim of this meta-analysis was to assess the effect of ICS treatment on the risk of fracture and osteoporosis in subjects with COPD. METHODS: This study included parallel-group randomized controlled trials (RCTs) comparing ICS and control (non-ICS) therapy for subjects with COPD that reported adverse events including fractures or osteoporosis. Studies were found using MEDLINE/PubMed, Embase, and Cochrane Library databases between 1998-September 2022. Pooled risk ratios (RRs) and 95% CIs were calculated for primary outcomes. RESULTS: A total of 61,380 participants from 26 RCTs were included in the meta-analysis. Exposure to ICS did not increase the risk of fracture (RR 1.10 [95% CI 0.98-1.23], P =.10) or osteoporosis risk (RR 0.93 [95% CI 0.49-1.79], P 5.84) in subjects with COPD. CONCLUSIONS: ICS use did not increase the incidence of fracture or osteoporosis in subjects with COPD.

引用

页码：1719 / 1727

页数：9

共 50 条

[1] Inhaled corticosteroids and fracture risk in COPD
Suissa, S
Ernst, P
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (01) : 94 - 94
[2] Inhaled corticosteroids in COPD: increased fracture risk?
Reactions Weekly, 2004, 998 (1) : 6 - 6
[3] Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
Liu, Shih-Feng
Kuo, Ho-Chang
Liu, Guan-Heng
Ho, Shu-Chen
Chang, Huang-Chih
Huang, Hung-Tu
Chen, Yu-Mu
Huang, Kuo-Tung
Chen, Kuan-Yi
Fang, Wen-Feng
Lin, Meng-Chih
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1607 - 1614
[4] COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
Ozcakir, Suheda
Sigirli, Deniz
Ursavas, Ahmet
Uzaslan, Esra
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2441 - 2448
[5] Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Snider, Julia Thornton
Luna, Yesenia
Wong, Ken S.
Zhang, Jie
Chen, Susan S.
Gless, Patrick J.
Goldman, Dana P.
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (12) : 1959 - 1967
[6] Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Thornton, Julia
Luna, Yesenia
Wong, Ken
Zhang, Jie
Chen, Susan
Goldman, Dana
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[7] Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
de Melo, MN
Ernst, P
Suissa, S
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (05) : 692 - 697
[8] The Risk of Sepsis with Inhaled and Oral Corticosteroids in Patients with COPD
Ernst, Pierre
Coulombe, Janie
Brassard, Paul
Suissa, Samy
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 14 (02) : 137 - 142
[9] Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture
Gonzalez, Anne V.
Coulombe, Janie
Ernst, Pierre
Suissa, Samy
CHEST, 2018, 153 (02) : 321 - 328
[10] Inhaled corticosteroids and risk of osteoporosis in asthma
Malerba, M
Radaeli, A
Mori, E
Romanelli, G
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (03) : 293 - 294

← 1 2 3 4 5 →